Predictors of the Risk of Mortality in Neurofibromatosis 2

Michael E. Baser; J.M. Friedman; Dana Aeschliman; Harry Joe; Andrew J. Wallace; Richard T. Ramsden; D. Gareth R. Evans

doi:10.1086/342716

journal article Open Access Oct 01, 2002

Predictors of the Risk of Mortality in Neurofibromatosis 2

Michael E. Baser J.M. Friedman Dana Aeschliman Harry Joe Andrew J. Wallace Richard T. Ramsden D. Gareth R. Evans

The American Journal of Human Genetics Vol. 71 No. 4 pp. 715-723 · Elsevier BV

View at Publisher Save 10.1086/342716

Topics

No keywords indexed for this article. Browse by subject →

References

38

[1]

Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas

J. Antinheimo, R. Sankila, O. Carpén et al.

Neurology 2000 10.1212/wnl.54.1.71

[2]

Baser "Predictors of survival in neurofibromatosis" Am J Hum Genet (1999)

[3]

Baser "Predictors of vestibular Schwannoma growth in patients with neurofibromatosis type 2" J Neurosurg (2002) 10.3171/jns.2002.96.2.0217

[4]

Baser "Phenotypic variability in monozygotic twins with neurofibromatosis 2" Am J Med Genet (1996) 10.1002/(sici)1096-8628(19960906)64:4<563::aid-ajmg7>3.0.co;2-q

[5]

Bruder "Severe phenotype of the neurofibromatosis type 2 gene in patients with a 7.4 Mbp constitutional deletion on chromosome 22: possible localization of a neurofibromatosis type 2 modifier gene?" Genes Chromosomes Cancer (1999) 10.1002/(sici)1098-2264(199906)25:2<184::aid-gcc15>3.0.co;2-b

[6]

Bruder "A group of schwannomas with interstitial deletions on 22q located outside the NF2 locus shows no detectable mutations in the NF2 gene" Hum Genet (1999) 10.1007/s004390050978

[7]

Buchman "The learning curve for acoustic tumor surgery" Laryngoscope (1996) 10.1097/00005537-199611000-00019

[8]

Charabi "Suboccipital acoustic neuroma surgery: results of decentralized neurosurgical tumor removal in Denmark" Acta Otolaryngol (1992) 10.3109/00016489209137478

[9]

Evans "Neurofibromatosis type 2" J Med Genet (2000) 10.1136/jmg.37.12.897

[10]

Evans "A clinical study of type 2 neurofibromatosis" Q J Med (1992)

[11]

A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity.

D G Evans, S M Huson, D Donnai et al.

Journal of Medical Genetics 1992 10.1136/jmg.29.12.841

[12]

Evans "Type 2 neurofibromatosis: the need for supraregional care?" J Laryngol Otol (1993) 10.1017/s002221510012328x

[13]

Evans "Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations" J Med Genet (1998) 10.1136/jmg.35.6.450

[14]

Evans "Somatic mosaicism: a common cause of classic disease in tumor-prone syndromes? lessons from type 2 neurofibromatosis" Am J Hum Genet (1998)

[15]

Gutmann "Defects in neurofibromatosis 2 protein function can arise at multiple levels" Hum Mol Genet (1998) 10.1093/hmg/7.3.335

[16]

Jackler "The perils of decentralized care in otology/neuro-otology" Am J Otol (1998)

[17]

Kino "Identification of the cis-acting region in the NF2 gene promoter as a potential target for mutation and methylation-dependent silencing in schwannoma" Genes Cells (2001) 10.1046/j.1365-2443.2001.00432.x

[18]

Kluwe "Identification of NF2 germ-line mutations and comparison with NF2 phenotypes" Hum Genet (1996) 10.1007/s004390050255

[19]

Kluwe "Phenotypic variability associated with 14 splice-site mutations in the NF2 gene" Am J Med Genet (1998) 10.1002/(sici)1096-8628(19980518)77:3<228::aid-ajmg8>3.0.co;2-l

[20]

Kluwe "Mosaicism in sporadic neurofibromatosis 2 patients" Hum Mol Genet (1998) 10.1093/hmg/7.13.2051

[21]

MacCollin "The diagnosis and management of neurofibromatosis 2 in childhood" Semin Pediatr Neurol (1998) 10.1016/s1071-9091(98)80003-x

[22]

Mautner "Vestibular schwannoma growth in patients with neurofibromatosis type 2: a longitudinal study" J Neurosurg (2002) 10.3171/jns.2002.96.2.0223

[23]

Mautner "The neuroimaging and clinical spectrum of neurofibromatosis 2" Neurosurgery (1996) 10.1097/00006123-199605000-00004

[24]

Mautner "Neurofibromatosis 2 in the pediatric age group" Neurosurgery (1993) 10.1227/00006123-199307000-00014

[25]

Mautner "Spinal tumors in patients with neurofibromatosis type 2: MR imaging study of frequency, multiplicity, and variety" AJR Am J Roentgenol (1995) 10.2214/ajr.165.4.7676998

[26]

McCarthy "Factors associated with survival in patients with meningioma" J Neurosurg (1998) 10.3171/jns.1998.88.5.0831

[27]

Mérel "Screening for germ-line mutations in the NF2 gene" Genes Chromosomes Cancer (1995) 10.1002/gcc.2870120206

[28]

Mosteller (1977)

[29]

Narod "Neurofibromatosis type 2 appears to be a genetically homogeneous disease" Am J Hum Genet (1992)

[30]

Parry "Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity" Am J Med Genet (1994) 10.1002/ajmg.1320520411

[31]

Parry "Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities" Am J Hum Genet (1996)

[32]

Rouleau "Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2" Nature (1993) 10.1038/363515a0

[33]

Ruttledge "Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease" Am J Hum Genet (1996)

[34]

Scoles "Neurofibromatosis 2 tumour suppressor schwannomin interacts with βII-spectrin" Nat Genet (1998) 10.1038/ng0498-354

[35]

Trofatter "A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor" Cell (1993) 10.1016/0092-8674(93)90406-g

[36]

Venables (1997)

[37]

Welling "The learning curve in vestibular schwannoma surgery" Am J Otol (1999)

[38]

Zucman-Rossi "NF2 gene in neurofibromatosis type 2 patients" Hum Mol Genet (1998) 10.1093/hmg/7.13.2095

Metrics

196

Citations

38

References

Details

Published: Oct 01, 2002
Vol/Issue: 71(4)
Pages: 715-723
License: View

Authors

Cite This Article

Michael E. Baser, J.M. Friedman, Dana Aeschliman, et al. (2002). Predictors of the Risk of Mortality in Neurofibromatosis 2. The American Journal of Human Genetics, 71(4), 715-723. https://doi.org/10.1086/342716

Predictors of the Risk of Mortality in Neurofibromatosis 2

You May Also Like